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Abstract
Background: Iron deficiency is common during pregnancy. Experimental animal studies suggest that it increases
cardiovascular risk in the offspring.
Objective: To examine the relationship between maternal pregnancy dietary and supplement iron intake and hemoglobin,
with offspring’s arterial stiffness (measured by carotid-radial pulse wave velocity), endothelial function (measured by
brachial artery flow mediated dilatation), blood pressure, and adiposity (measured by body mass index), test for mediation
by cord ferritin, birth weight, gestational age, and child dietary iron intake, and for effect modification by maternal vitamin C
intake and offspring sex.
Design: Prospective data from 2958 mothers and children pairs at 10 years of age enrolled in an English birth cohort, the
Avon Longitudinal Study for Parents and Children (ALSPAC), was analysed.
Results: 2639 (89.2%) mothers reported dietary iron intake in pregnancy below the UK reference nutrient intake of 14.8 mg/
day. 1328 (44.9%) reported taking iron supplements, and 129 (4.4%) were anemic by 18 weeks gestation. No associations
were observed apart from maternal iron intake from supplements with offspring systolic blood pressure (20.8 mmHg, 99%
CI 21.7 to 0, P = 0.01 in the sample with all relevant data observed, and 20.7 mmHg, 99% CI 21.3 to 0, P = 0.008 in the
sample with missing data imputed).
Conclusion: There was no evidence of association between maternal pregnancy dietary iron intake, or maternal
hemoglobin concentration (which is less likely to be biased by subjective reporting) with offspring outcomes. There was a
modest inverse association between maternal iron supplement intake during pregnancy with offspring systolic blood
pressure at 10 years.
Citation: Alwan NA, Cade JE, Greenwood DC, Deanfield J, Lawlor DA (2014) Associations of Maternal Iron Intake and Hemoglobin in Pregnancy with Offspring
Vascular Phenotypes and Adiposity at Age 10: Findings from the Avon Longitudinal Study of Parents and Children. PLoS ONE 9(1): e84684. doi:10.1371/
journal.pone.0084684
Editor: Franc¸ois Blachier, National Institute of Agronomic Research, France
Received August 30, 2013; Accepted November 18, 2013; Published January 6, 2014
Copyright:  2014 Alwan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Core support for ALSPAC is provided by the UK Medical Research Council, the Wellcome Trust and the University of Bristol. Funding for the vascular
measurements used in this study was obtained from the British Heart Foundation. NAA is funded by a Wellcome Trust research fellowship [WT87789] and DAL
works in a Unit that receives funding from the UK Medical Research Council [grant number MC_UU_12013/5]. The study funders had no role in study design,
analysis and interpretation of data, the writing of the article or the decision to submit for publication. The views expressed in this paper are those of the authors
and not necessarily any of the funding agencies that have supported this work.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: N.Alwan@leeds.ac.uk
Introduction
Iron is an essential micronutrient important in carrying oxygen,
and to the catalytic activity of a variety of enzymes. In the fetus, it
is used to synthesize hemoglobin, and is integral to brain
development [1]. Iron deficiency is the most common nutrient
deficiency in the world [2], with 25–40% of pregnant women in
Western societies estimated to have iron deficiency [3]. Iron
deficiency anemia in pregnancy has been linked to low
birthweight, preterm delivery and perinatal iron deficiency anemia
[4,5,6,7,8].
These short-term adverse effects may reflect an impact of iron
deficiency on placental structure and function, which may have
long-term effects via fetal organ development [9]. Evidence from
animal models suggests that maternal iron deficiency during
pregnancy can result in the development of obesity and
hypertension in the offspring [10,11,12,13], but evidence in
humans remains inconclusive. In a previous analysis of data from
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the same birth cohort we analysed, the Avon Longitudinal Study
of Parents and Children (ALSPAC) cohort, Brion et al reported an
association between maternal anemia and offspring blood pressure
(BP) at 7 years in women who did not take iron supplements
during pregnancy [14]. Belfort et al, with a sample size of 1167 US
pregnant women, did not find an association between first and
second trimester maternal anemia with offspring BP at 3 years.
However, offspring BP was positively associated with first trimester
iron intake, in contrast to animal studies findings [10,11,12,13],
while no relationship was observed for second trimester iron intake
[15]. Other studies examining the association between maternal
anemia in pregnancy and offspring childhood BP reported
conflicting findings ranging from positive to negative, and
including null associations [16,17,18,19].
Maternal iron status in pregnancy is strongly associated with
umbilical cord ferritin [20,21,22]. Thus, cord ferritin could
mediate any intrauterine effect of maternal iron status on later
offspring cardiovascular outcomes. Animal studies suggest that
the inverse association of maternal iron status with later
offspring cardiovascular outcomes differs by offspring gender,
being stronger in males [11,23]. Furthermore, since vitamin C is
a key enhancer of iron absorption [24,25], the relationship
between maternal iron intake and perinatal or longer term
outcomes may be stronger with adequate intake of vitamin C
[26].
We aim to examine the relationship between indicators of
maternal iron status in pregnancy and indicators of child’s
circulatory health. In this study, we extended the work done by
Brion et al using ALSPAC data [14], aiming to examine the
associations between maternal iron intake and hemoglobin
concentrations during pregnancy with offspring‘s BP at a later
age (10 years) than the previous analysis, plus including
offspring adiposity as assessed by body mass index, and other
offspring vascular indicators; endothelial function as assessed by
brachial artery flow mediated dilatation, and arterial stiffness as
assessed by carotid-radial pulse wave velocity. We examined
whether any observed associations were mediated by cord blood
ferritin levels, gestational age, offspring’s birthweight, and
dietary iron intake and explored whether offspring sex and
maternal vitamin C intake moderate any associations.
Subjects and Methods
ALSPAC is a longitudinal, population-based birth cohort study
which recruited pregnant women (n= 14541 pregnancies) from
the South West of England between 1990 and 1992 and has
followed the parents and offspring since then. The cohort is
described in detail elsewhere [27,28]. Please note that the study
website contains details of all the available data through a fully
searchable data dictionary (www.bris.ac.uk/alspac/researchers/
data-access/data-dictionary). Ethical approval was obtained from
the ALSPAC Law and Ethics Committee and the local research
ethics committees, and procedures were in accordance with the
Helsinki Declaration of 1975 as revised in 1983. Participants
provided their written informed consent to participate in this
study.
Figure 1 shows participants flow-chart for the complete case
analysis performed for this study.
Figure 1. Participants flow chart.
doi:10.1371/journal.pone.0084684.g001
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Exposure Assessment
Iron intake from food was assessed using a food-frequency
questionnaire (FFQ) sent to mothers at 32 weeks gestation
covering all the main foods consumed in Britain. Mothers were
asked how often they were currently consuming each of 43 food
groups [29]. Intakes for a range of nutrients, including iron, were
derived using nutrient information on standard-sized portions
based on the 5th edition of McCance and Widdowson’s
Composition of Food tables [30]. The FFQ was used to calculate
an approximate daily nutrient intake for each woman by
multiplying the weekly frequency of consumption of a food by
the nutrient content. The nutrient values obtained were then
divided by seven to convert this to a daily intake including energy,
protein, total fat, saturates, monounsaturates and polyunsaturates,
total sugar, non-milk extrinsic sugar, dietary fibre, nine vitamins
and five minerals [29].
Maternal iron supplement use was obtained from questionnaires
sent at 18 weeks gestation (relating to anytime during pregnancy
before the questionnaire date), and 32 weeks gestation (relating to
3 months of pregnancy between the first and second question-
naire). Mothers were asked whether they had taken iron
supplements, vitamins, or any other supplements. In a separate
question, women were also asked to list all pills, medicines, and
ointments they used, with a reminder to include iron tablets,
vitamins, herbal medicines, etc. Responses at 18 and 32 weeks
regarding iron supplements were combined to generate a binary
variable (yes/no) for ‘iron supplement used anytime during
pregnancy up to 32 weeks gestation’.
Maternal hemoglobin concentrations were extracted from
antenatal medical records of study participants as it was measured
routinely in all pregnancy women. An ‘Early pregnancy hemo-
globin’ variable was derived, defined as the first measurement of
hemoglobin before 18 weeks. A mother was classified as having
‘early pregnancy anemia’ if her hemoglobin measurement was less
than 11 g/dl, the threshold used to define pregnancy anemia
according to World Health Organization guidelines [31].
Outcome Assessment
BP, pulse wave velocity, flow mediated dilatation and body
mass index were measured in child clinics at ages 10–11 years
by six trained research technicians/fieldworkers over a two year
study period [32]. Carotid-radial pulse wave velocity was
measured transcutaneously using a high-fidelity micromanome-
ter (SPC-301, Millar Instruments, Houston, TX, USA). Ultra-
sound images of the right brachial artery were used to measure
flow mediated dilatation percentage. The coefficients of
variation between technicians for flow mediated dilatation and
pulse wave velocity were 10.5% and 4.6% respectively at the
beginning of the study, and reached 7.7% and 4.1% at the end
of the study. Detailed description of the measurement methods
is available elsewhere [32]. Flow mediated dilatation reflects
endothelium-dependent vasodilator function, which is considered
prognostic of cardiovascular risk [33,34]. Pulse wave velocity
measures the time taken for the systolic pressure wave to travel
a known distance, and is increasingly considered a convenient,
reliable and integrated index of vascular pathology over the
lifecourse [35]. Weight to the nearest 0.1 kg was measured in
light clothing and without shoes using SECA scales. Height to
the nearest 0.1 cm was measured using a Leicester height
meter. From these, body mass index was calculated (weight in
kg/height in metres2).
Table 1. Study sample characteristics (complete cases for exposures, outcomes, confounders and mediators n = 2958) and ALSPAC
sample characteristics (with dietary iron intake data n = 12116).
Complete case sample ALSPAC sample (with dietary data)
Dietary iron intake# (mg/day) (m, sd*) 10.7 (3.2) 10.4 (3.4)
Dietary iron intake ,UK RNI## (%, 95% CI**) 89.2 (88.0, 90.3) 90.3 (89.7, 90.8)
Dietary iron intake ,UK LRNI### (%, 95% CI) 18.0 (16.7, 19.5) 25.0 (24.2, 25.8)
Dietary vitamin C intake## (mg/day) (m, sd) 85.9 (34.5) 80.1 (35.3)
Age of mother (yrs) (m, sd) 29.5 (4.2) 28.5 (4.8)
Pre-pregnancy BMI (kg/m2) (m, sd) 22.8 (3.5) 22.9 (3.6)
Total energy intake (kj) (m, sd) 7,483 (1,908) 7,415 (2,081)
Smoking in pregnancy (%, 95% CI**) 15.4 (14.1, 16.7) 25.2 (24.4, 26.0)
Caucasian (%, 95% CI) 98.8 (98.4, 99.2) 97.5 (97.2, 97.8)
University degree (%, 95% CI) 18.6 (17.2, 20.0) 13.8 (13.1, 14.4)
Vegetarian (%, 95% CI) 6.1 (5.3, 7.0) 5.2 (4.8, 5.6)
Primigravida (%, 95% CI) 48.8 (47.0, 50.6) 44.8 (43.9, 45.7)
Early pregnancy maternal anemia (,11 g/dL) (%, 95% CI) 4.4 (3.7, 5.1) 5.1 (4.6, 5.5)
Report taking iron supplements Before 32 wks gestation (%, 95% CI) 44.9 (43.1, 46.7) 47.5 (46.6, 48.4)
Child gender (male) (%, 95% CI) 50.8 (49.0, 52.6) 51.5 (50.6, 52.4)
Birthweight (g) (m, sd) 3,448 (499) 3,411 (544)
Gestational age (wks) (m, sd) 39.6 (1.6) 39.5 (1.8)
#Food frequency questionnaire at 32 weeks gestation.
##UK Reference Nutrient Intake (14.8 mg/day).
###UK Lower Reference Nutrient Intake (8 mg/day).
*Mean, standard deviation.
**95% confidence intervals.
doi:10.1371/journal.pone.0084684.t001
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Covariables
Current age of the child was recorded in months at the time of
the assessment clinic. Child sex was recorded at birth from the
obstetric records. We considered the following covariables to be
potential confounders (associated with both exposures and
outcomes); maternal age, pre-pregnancy body mass index,
educational level (as a marker of socioeconomic status), smoking
in pregnancy, parity, and maternal total energy intake as assessed
by food frequency questionnaire at 32 weeks.
Highest maternal educational qualification was self-reported at
32 weeks gestation, and was categorized as university degree, A-
level or equivalent (A-level is Advanced-level and indicates a
qualification usually taken around 18 years of age by individuals
who have remained in school beyond the legal minimum age at
which they can leave (16 years) and are likely to go on to higher or
further education or train for a semi-skilled job), and less than A-
level. Maternal smoking was self-reported at the 18 and 32 weeks
gestation questionnaire. A variable was generated for any smoking
during pregnancy reported at either or both of these time points.
On the basis of it being plausible that maternal iron status would
affect them and that they could plausibly causally affect the
offspring’s cardiovascular profile [36,37], we considered the
following potential mediators of the association; cord ferritin,
gestational age, offspring birthweight and offspring dietary iron
intake. Gestational age at delivery and birthweight were obtained
from the obstetric records. Ferritin was measured in cord heparin
plasma at the ALSPAC laboratory using the DELFIA time
resolved fluoroimmunoassay system. Ferritin assays were dupli-
cated where possible and a coefficient of variation of approxi-
mately 4% was obtained. Offspring dietary iron intake was
assessed by a food frequency questionnaire administered at 3, 4, 7
and 9 years of age [38]. We used the mean iron intake of these 4
assessments. Maternal vitamin C intake (which we considered a
potential effect modifier of maternal iron status on offspring
outcomes) was calculated from the food frequency questionnaire as
described above for iron intake. A binary variable for dietary
vitamin C intake was created using the UK Reference Nutrient
Intake cut-off of 50 mg/day and used to test for interaction [39].
Baby’s sex (also a potential effect modifier) was obtained from the
birth records.
Statistical Analysis
Analysis was performed using Stata version 11 (StataCorp LP,
College Station, TX, USA). Characteristics of women with iron
intake above or equal to the reference nutrient intake were
compared to those with intake below the reference nutrient intake
using two-sample t-test for continuous variables and chi-squared
test for categorical variables.
Linear regression was used to examine the association of
maternal dietary iron intake (assessed as a continuous variable per
Table 2. Sample characteristics by dietary iron intake as assessed by food frequency questionnaire at 32 weeks gestation (n = 2958
for all, except where cord ferritin data is used: n = 795).
Dietary iron intake
$14.8 mg/day# (n = 319) ,14.8 mg/day (n =2,639) P value*
Dietary iron intake## (mg/day) (m, sd**) 16.9 (1.9 ) 10.1 (2.5) –
Dietary vitamin C intake## (mg/day) (m, sd) 119.3 (35.6) 81.8 (32.1) ,0.001
Age of mother (yrs) (m, sd) 30.0 (4.2) 29.5 (4.2) 0.02
Pre-pregnancy BMI (kg/m2) (m, sd) 21.7 (2.5) 22.9 (3.6) ,0.001
Total energy intake (kj) (m, sd) 10,100 (1,921) 7,167 (1,645) ,0.001
Smoking in pregnancy (%, 95% CI***) 10.7 (7.5, 14.6) 15.0 (14.6, 14.4) 0.001
Caucasian (%, 95% CI) 98.1 (96.0, 99.3) 99.0 (98.4, 99.3) 0.2
University degree (%, 95% CI) 27.0 (22.2, 32.2) 17.6 (16.2, 19.1) ,0.001
Vegetarian (%, 95% CI) 11.9 (8.3, 16.6) 5.5 (4.6, 6.4) ,0.001
Primigravida (%, 95% CI) 48.0 (42.4, 53.6) 51.0 (47.0, 50.9) 0.8
Early pregnancy maternal anemia (,11 g/dL) (%, 95% CI) 6.6 (4.1, 9.9) 4.1 (3.4, 4.9) 0.04
Report taking iron supplements Before 32 wks gestation (%, 95% CI) 48.3 (42.7, 53.9) 44.5 (42.6, 46.4) 0.2
Cord ferritin (mg/L) (m,sd) 151.9 (104.8) (n =283) 165.4 (123.6) (n = 712) 0.3
Child systolic blood pressure (mmHg) (m, sd) 103.9 (8.7) 103.6 (8.8) 0.5
Child diastolic blood pressure (mmHg) (m, sd) 60.3 (7.3) 59.5 (7.8) 0.08
Child pulse wave velocity (m/s) (m, sd) 7.7 (1.3) 7.5 (1.2) 0.1
Child flow mediated dilatation (%) (m, sd) 8.3 (3.5) 8.0 (3.4) 0.1
Child body mass index (kg/m2) (m, sd) 17.9 (2.7) 18.1 (3.0) 0.2
Child gender (male) (%, 95% CI) 55.2 (49.5, 60.7) 50.3 (48.3, 52.2) 0.1
Birthweight (g) (m, sd) 3,439 (486) 3,450 (500) 0.7
Gestational age (wks) (m, sd) 39.5 (1.6) 39.6 (1.6) 0.3
#Reference nutrient intake (RNI) for iron for women aged 19–50 years in the UK.
##Food frequency questionnaire at 32 weeks gestation.
*P-value using two-sample t-test for continuous variables, chi-squared test for categorical variables.
**Mean, standard deviation.
***95% confidence intervals.
doi:10.1371/journal.pone.0084684.t002
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Table 3. Linear regression estimates for associations between maternal iron intake and hemoglobin in pregnancy with offspring vascular indicators and body mass index
(n = 2958 for all, except where cord ferritin data is used: n = 795).
Offspring pulse wave
velocity (m/s)
Offspring flow mediated
dilatation (%)
Offspring systolic blood
pressure (mmHg)
Offspring diastolic blood
pressure (mmHg)
Offspring body mass
index (kg/m2)
B 99% CIH P B 99% CIH P B 99% CIH P B 99% CIH P B 99% CIH P
Maternal pregnancy dietary iron intake (continuous) (per 10 mg/d)
Unadjusted 0.2 0, 0.4 0.02 0.2 20.4, 0.6 0.5 20.6 21.9, 0.7 0.3 0.4 20.8, 1.5 0.4 20.8 21.3, 20.4 ,0.001
Model 1# 0.1 20.2, 0.4 0.5 0.4 20.3, 1.2 0.1 20.3 22.2, 1.7 0.7 0.7 21.1, 2.4 0.3 0.1 2.0.5, 0.7 0.7
Model 2* 0.1 20.2, 0.4 0.3 0.5 20.3, 1.2 0.1 20.1 22.1, 2.0 0.9 1.0 20.8, 2.8 0.2 0.1 20.6, 0.7 0.8
Model 3** 0.5 20.1, 1.1 0.04 0.3 21.2, 1.9 0.6 0.7 23.5, 4.9 0.7 1.2 22.4, 4.8 0.4 0.2 21.1, 1.5 0.7
Maternal iron intake ,14.8 mg/d
Unadjusted 20.1 20.3, 0.1 0.1 20.3 20.8, 0.2 0.1 20.3 21.7, 1.0 0.5 20.8 22.0, 0.4 0.08 0.2 20.2, 0.7 0.2
Model 1# 0 20.3, 20.2 0.7 20.5 21.1, 0.1 0.05 20.7 22.3, 0.8 0.3 20.9 22.3, 0.4 0.08 20.4 20.9, 0.1 0.03
Model 2* 0 20.3, 0.2 0.7 20.5 21.1, 0.1 0.04 20.8 22.3, 0.8 0.2 21.0 22.4, 0.3 0.05 20.4 20.9, 0.1 0.03
Model 3** 20.1 20.6, 0.3 0.5 0.1 21.0, 1.2 0.8 20.8 23.9, 2.2 0.5 21.2 23.9, 1.5 0.3 20.5 21.5, 0.4 0.2
Maternal pregnancy iron supplement use
Unadjusted 20.1 20.1, 0.2 0.07 0.2 20.1, 0.5 0.1 21.0 21.8, 20.1 0.003 20.4 21.1, 0.3 0.2 20.1 20.4, 0.2 0.3
Model 1# 0.1 20.1, 0.2 0.2 0.2 20.1, 0.6 0.07 20.8 21.7, 0 0.01 20.3 21.1, 0.4 0.3 0 20.2, 0.3 0.7
Model 2* 0.1 20.1, 0.2 0.1 0.2 20.1, 0.6 0.06 20.8 21.6, 0.1 0.02 20.2 21.0, 0.5 0.5 0 20.3, 0.3 0.9
Model 3** 0 20.2, 0.3 0.7 0.1 20.6, 0.7 0.8 20.9 22.6, 0.8 0.2 0.1 21.4, 1.5 0.9 20.2 20.7, 0.3 0.4
Maternal early pregnancy hemoglobin (g/dL)
Unadjusted 20.1 20.1, 0 0.07 20.1 20.2, 0.1 0.5 0.4 20.1, 0.8 0.05 0 20.4, 0.4 0.8 0.1 0, 0.3 0.06
Model 1# 0 20.1, 0 0.09 20.1 20.3, 0.1 0.3 0.2 20.3, 0.7 0.2 0 20.5, 0.4 0.8 0 20.2, 0.1 0.7
Model 2* 20.1 20.1, 0 0.08 20.1 20.3, 0.1 0.3 0.2 20.3, 0.7 0.3 20.1 20.5, 0.4 0.7 0 20.2, 0.2 0.9
Model 3** 20.1 20.2, 0.1 0.3 0 20.4, 0.3 0.8 0.3 20.6, 1.3 0.4 20.1 20.9, 0.7 0.7 0.1 20.2, 0.4 0.6
Maternal early pregnancy anemia (,11 g/dL)
Unadjusted 0 20.3, 0.3 0.8 20.2 21.0, 0.6 0.5 21.5 23.6, 0.6 0.06 0.4 22.2, 1.4 0.5 20.1 20.8, 0.6 0.6
Model 1# 0 20.3, 0.3 0.8 20.2 21.0, 0.6 0.6 21.3 23.3, 0.8 0.1 20.3 22.1, 1.5 0.6 0.1 20.5, 0.8 0.7
Model 2* 0 20.3, 0.3 0.8 2.0.2 20.9, 0.6 0.6 21.2 23.2, 0.9 0.1 20.2 22.0, 1.6 0.7 0 20.6, 0.7 0.8
Model 3** 0 20.7, 0.3 0.2 20.1 21.4, 1.3 0.9 21.0 24.6, 2.6 0.5 20.3 23.4, 2.8 0.8 0.1 21.0, 1.2 0.7
#Adjusting for confounders: maternal age, pre-pregnancy body mass index, smoking in pregnancy, educational qualification (as a proxy for socioeconomic status), parity (and maternal total energy intake in the models with dietary
iron intake as exposure).
*Adjusting for confounders and three mediators: birth weight, gestational age, offspring dietary iron intake.
**Adjusting for confounders and four mediators: birth weight, gestational age, offspring dietary iron intake, cord ferritin.
Hconfidence intervals.
doi:10.1371/journal.pone.0084684.t003
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Table 4. Multivariable linear regression for associations between maternal iron intake and hemoglobin in pregnancy with offspring vascular indicators and body mass index using
multiple imputation dataset based on the sample with dietary iron intake data (n = 12116).
Offspring pulse wave
velocity (m/s)
Offspring flow mediated
dilatation (%)
Offspring systolic blood
pressure (mmHg)
Offspring diastolic blood
pressure (mmHg)
Offspring body mass
index (kg/m2)
B 99% CIH P B 99% CIH P B 99% CIH P B 99% CIH P B 99% CIH P
Maternal pregnancy dietary iron intake (continuous) (per 10 mg/d)
Unadjusted 0 20.1, 0.1 0.3 0.1 20.3, 0.4 0.6 21.0 21.9, 20.1 0.004 20.5 21.3, 0.3 0.1 20.7 21.1, 20.4 ,0.001
Model 1# 20.1 20.2, 0.1 0.5 0.5 20.1, 1.0 0.03 0.2 21.9, 1.4 0.7 20.3 21.6, 1.0 0.6 0.2 20.3, 0.7 0.3
Model 2* 0 20.4, 0.3 0.5 0.5 20.1, 1.0 0.02 0 21.6, 1.6 0.9 0 21.3, 1.4 0.9 0.1 20.4, 0.6 0.6
Model 3** 0 20.2, 0.1 0.5 20.2 20.1, 1.1 0.6 0.1 21.7,1.6 0.9 0 21.4, 1.4 0.9 0 20.4, 0.6 0.6
Maternal iron intake ,14.8 mg/d
Unadjusted 20.1 20.2, 0 0.06 20.2 20.6, 0.2 0.1 0.6 20.4, 1.6 0.1 0 20.9, 0.9 0.9 0.3 0.1, 0.6 0.002
Model 1# 20.1 20.2, 0.1 0.3 20.4 20.8, 0.1 0.03 0 21.3, 1.3 0.9 20.3 21.3, 0.7 0.5 20.2 20.5, 0.1 0.06
Model 2* 20.1 20.2, 0.1 0.2 20.4 20.8, 0.1 0.03 20.1 21.3, 1.2 0.9 20.4 21.4, 0.6 0.3 20.2 20.5, 0.1 0.08
Model 3** 20.1 20.2, 0.1 0.2 20.4 20.8, 0.1 0.02 20.1 21.3, 1.2 0.9 20.4 21.4, 0.6 0.3 20.2 20.5, 0.1 0.08
Maternal pregnancy iron supplement use
Unadjusted 0.1 0, 0.1 0.2 0.1 20.1, 0.4 0.2 20.8 21.4, 20.2 0.001 20.3 20.8, 0.2 0.2 20.2 20.4, 0 0.002
Model 1# 0 20.1, 0.1 0.3 0.1 20.1, 0.4 0.1 20.7 21.3, 0 0.008 20.2 20.7, 0.4 0.4 0 20.2, 0.2 0.9
Model 2* 0 20.1, 0.1 0.2 0.2 20.1, 0.4 0.08 20.6 21.2, 0 0.01 20.1 20.7, 0.4 0.5 20.1 20.2, 0.1 0.5
Model 3** 0 0, 0.1 0.2 0.2 20.1, 0.4 0.08 20.6 21.3, 0 0.01 20.2 20.7, 0.4 0.4 0 20.2, 0.1 0.5
Maternal early pregnancy hemoglobin (g/dL)
Unadjusted 0 20.1, 0 0.1 0 20.1, 0.1 0.8 0.3 20.1, 0.7 0.05 0.1 20.3, 0.4 0.6 0.1 0, 0.3 0.02
Model 1# 0 20.1, 0 0.3 0 20.1, 0.1 0.9 0.2 20.2, 0.5 0.3 0 20.3, 0.3 0.8 20.1 20.2, 0.1 0.2
Model 2* 0 20.1, 0 0.3 0 20.1, 0.1 0.9 0.1 20.2, 0.5 0.3 0 20.4, 0.3 0.8 0 20.2, 0.1 0.3
Model 3** 0 20.1, 0 0.3 0 20.1, 0.1 0.9 0.1 20.2, 0.5 0.3 0 20.3, 0.3 0.8 20.1 20.2, 0.1 0.3
Maternal early pregnancy anemia (,11 g/dL)
Unadjusted 0 20.3, 0.2 0.6 0 20.6, 0.6 0.9 20.1 21.5, 1.2 0.8 0 21.4, 1.2 0.9 0.1 20.5, 0.6 0.8
Model 1# 20.1 20.3, 0.2 0.6 0 20.6, 0.6 0.9 0.1 21.2, 1.5 0.8 0.2 21.2, 1.6 0.8 0.4 20.2, 0.9 0.07
Model 2* 20.1 20.3, 0.2 0.5 0 20.6, 0.6 0.9 0.1 21.2, 1.5 0.8 0.1 21.3, 1.5 0.8 0.4 20.2, 0.9 0.08
Model 3** 20.1 20.3, 0.2 0.5 0 20.6, 0.6 0.9 0.1 21.2, 1.5 0.8 0.2 21.2, 1.6 0.7 0.4 20.2, 0.9 0.07
#Adjusting for confounders: maternal age, pre-pregnancy body mass index, smoking in pregnancy, educational qualification (as a proxy for socioeconomic status), parity (and maternal total energy intake in the models with dietary
iron intake as exposure).
*Adjusting for confounders and three mediators: birth weight, gestational age, offspring dietary iron intake.
**Adjusting for confounders and four mediators: birth weight, gestational age, offspring dietary iron intake, cord ferritin.
Hconfidence intervals.
doi:10.1371/journal.pone.0084684.t004
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Table 5. Multivariable linear regression estimates from stratified analyses for associations between maternal iron intake and hemoglobin in pregnancy with offspring vascular
indicators and body mass index with testing for effect modification by maternal vitamin C intake during pregnancy and child sex (n = 2958).
Offspring pulse wave
velocity (m/s)
Offspring flow mediated
dilatation (%)
Offspring systolic blood
pressure (mmHg)
Offspring diastolic blood
pressure (mmHg)
Offspring body mass
index (kg/m2)
B# 99% CIH P* B# 99% CIH P* B# 99% CIH P* B# 99% CIH P* B# 99% CIH P*
Maternal pregnancy dietary iron intake (continuous) (per 10 mg/d)
In participants with vitamin C
intake .50 mg/day
0 20.3, 0.3 0.5 0.6 20.2, 1.5 0.5 20.3 22.4, 1.9 0.7 0.8 21.1, 2.7 0.8 0 2.0.7, 0.6 0.3
In participants with vitamin C
intake #50 mg/day
0.2 20.7, 1.1 20.3 22.7, 2.1 21.8 27.3, 3.7 1.2 24.0, 6.4 1.2 21.1, 3.5
Males 0.2 20.2, 0.6 0.4 0.6 20.4, 1.6 0.2 0.4 22.3, 3.1 0.9 0.9 21.5, 3.2 0.7 0.2 20.7, 1.0 0.4
Females 0 20.4, 0.4 0.5 20.7, 1.6 20.9 23.8, 2.0 0.7 21.9, 3.3 0.1 20.9, 1.0
Maternal pregnancy iron supplement use
In participants with vitamin C
intake .50 mg/day
0 20.1, 0.2 0.2 0.3 0, 0.7 0.1 20.8 21.7, 0.1 0.9 20.4 21.2, 0.5 0.9 0.1 20.2, 0.3 0.9
In participants with vitamin C
intake #50 mg/day
0.2 20.1, 0.5 20.3 21.1, 0.6 20.8 22.7, 1.2 20.1 22.0, 1.8 0 20.8, 0.8
Males 0.1 20.1, 0.2 0.8 0.2 20.2, 0.6 0.9 20.9 22.1, 0.3 0.7 20.9 21.9, 0.1 0.06 20.1 20.4, 0.3 0.5
Females 0.1 20.1, 0.2 0.3 20.3, 0.7 20.7 21.9, 0.5 0.2 20.8, 1.3 0.1 20.3, 0.5
Maternal early pregnancy anemia (,11 g/dL)
Males 0 20.4, 0.4 0.9 0.2 20.9, 1.2 0.3 21.3 24.1, 1.4 0.8 0.3 22.1, 2.6 0.4 0.4 20.5, 1.2 0.2
Females 20.1 20.5, 0.4 20.5 21.7, 0.7 21.0 24.1, 2.1 20.9 23.7, 1.8 20.2 21.2, 0.8
#Adjusting for potential confounding characteristics: maternal age, pre-pregnancy BMI, smoking in pregnancy, educational qualification (as a proxy for socioeconomic status), parity, and maternal total energy intake in the models
with dietary iron intake as exposure).
Hconfidence intervals.
*Interaction P value, testing the null hypotheses that associations do not differ by maternal vitamin C level or by sex of participants.
doi:10.1371/journal.pone.0084684.t005
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10 mg/day and also as a binary variable,versus $14.8 mg/day),
whether or not the mother took iron supplements in pregnancy
and early pregnancy hemoglobin (assessed as a continuous 1 g/dL
and as a binary variable,versus $11 g/dL) with offspring pulse
wave velocity, flow mediated dilatation, BP and body mass index
all measured at mean age 10 years. Initially, univariable (no
adjustment for covariables) analyses were undertake followed by
multivariable models that adjusted first for potential confounding
factors (maternal age, pre-pregnancy body mass index, educational
level, smoking in pregnancy, parity, and maternal total energy
intake for analyses involving dietary iron intake as the exposure),
then for potential mediation by birthweight, gestational age and
offspring postnatal dietary iron intake. Finally, in the subgroup
with data on cord ferritin levels, its role as a mediator was
examined.
The possibilities that offspring sex or maternal adequate intake
of vitamin C (# versus .50 mg/day) modified the association of
maternal exposures with offspring outcomes were assessed by
examining stratified (by sex and maternal adequate vitamin C
intake) analyses and by including an interaction term in the
confounder adjusted models.
A statistical significance level of 1%, with 99% confidence
intervals, was used in the regression models to reduce the risk of
type I error due to multiple statistical testing.
Sensitivity Analyses
We undertook sensitivity analysis aimed at exploring whether
missing data might have led to biased estimates. To do this, we
used multivariable multiple imputation in Stata as described by
Royston [40] to impute missing values for variables included in the
main analysis models for any ALSPAC participant in the 12116
sample with dietary iron intake data. Twenty imputation datasets
were generated in which missing variables values were imputed by
chained equations including exposures, outcomes and covariables
as used in the main confounder-adjusted models. The sensitivity
analysis results are obtained by averaging over the results from
each of the 20 datasets using Rubin’s rules [40].
We also carried out another sensitivity analysis, adding maternal
hemoglobin to the models exploring the associations of maternal
iron supplement intake with childhood outcomes. This was to
account for potential reverse causality (the reason for taking the
iron supplements is the mother’s awareness of being anaemic).
Results
The main analysis sample was 2958 with complete data on all
exposures, outcomes, confounders and mediators (except for cord
ferritin). A description of the study sample characteristics,
compared with the total ALSPAC sample with dietary data is
shown in table 1. Mean maternal pregnancy iron intake was
10.7 mg/day (standard deviation= 3.2). The mean age of the child
at the time of the focus clinic was 119 months (9.9 years, standard
deviation = 0.3). Table 2 summarized participants’ characteristics
by maternal iron intake. Women with dietary iron intake equal to
or more than the UK Reference Nutrient Intake for iron were
more likely to be older, vegetarian, with higher educational
qualification, report higher total energy and vitamin C intake,
have lower pre-pregnancy body mass index, and were less likely to
smoke during pregnancy.
In unadjusted analyses, maternal dietary iron intake was
associated with offspring body mass index, and maternal
pregnancy supplement intake was associated with offspring systolic
BP. With adjustment for confounding characteristics, there were
no associations between the primary exposures and outcomes of
interest apart from the inverse association between maternal iron
supplement intake and offspring systolic BP which remained
largely unchanged, with marginal statistical significance at the 1%
significance level (0.8 mmHg lower with reporting taking iron
supplements, 99% CI 0 to 1.7, P= 0.01). This association was not
markedly affected by adjustment for mediators (birthweight,
gestational age, and offspring dietary iron intake), but was
attenuated to the null in the smaller sub-sample with further
adjustment for cord ferritin as a fourth mediator (table 3).
The main adjusted associations were largely similar when
conducted using the multiple imputation databases (table 4),
compared to those conducted on complete data presented as
primary analyses in this paper (table 3). However, adjusting for
cord ferritin as a mediator in the inverse association between
maternal iron supplement use and offspring systolic BP in the
imputed dataset had less impact than in the complete dataset
(table 4).
Adjusting for early pregnancy maternal hemoglobin in the
association between maternal iron supplement use and offspring
systolic BP as sensitivity analysis did not change the magnitude of
association (20.8 mmHg, 99% CI 0.1 to 21.7, P = 0.03 in the
main complete dataset, and 20.6 mmHg, 99% CI 0 to 21.3,
P= 0.01 in the imputed dataset).
There was also no evidence of effect modification by maternal
vitamin C intake or child sex on any of the relationships (table 5).
There was also no association between cord ferritin and either
maternal dietary iron intake or hemoglobin.
Discussion
In this study, we have examined associations of maternal
pregnancy iron intake and early-pregnancy hemoglobin with
several markers of offspring cardiovascular health at 10 years. Of
the 25 main associations that we examined only one was observed,
that of an inverse association of maternal report of taking a
supplement that contained iron before 32 weeks gestation with
offspring systolic BP at 10 years of age. However, although the
direction of the latter association is consistent with results from
previous animal studies [10,11,12,13], its magnitude was modest
(1 mmHg lower offspring systolic BP on average in children whose
mothers reported taking supplements compared to those who did
not). To take some account of multiple testing, we have used a p-
value threshold of 0.01, giving this association only marginal
statistical significance in the main complete dataset. Therefore, this
result should be treated with caution as a potential chance finding.
This association could be heavily confounded by the detection of
anemia or iron deficiency in the mother. We have taken account of
the potential confounding of maternal hemoglobin in a sensitivity
analysis which did not change this result much. However, the
detection of iron deficiency during antenatal care by measuring
serum ferritin concentration could still constitute unmeasured
confounding.
Our findings suggest that the markers for maternal iron status
used in this study (dietary iron intake and hemoglobin concentra-
tions) are unlikely to be related to childhood indicators of
cardiovascular health at 10 years. However, they do not exclude
a relationship that could become apparent later in the offspring’s
lives. In the previous analysis in ALSPAC by Brion et al which
reported an association between maternal anemia and offspring
BP at 7 years only in women who did not take iron supplements
during pregnancy, the sample size with data on maternal
hemoglobin (before stratification by supplement intake) was
considerably smaller (n = 1255) than our analysis (n = 2958) [14].
Also the definition of early anemia differed in that analysis in that
Iron in Pregnancy and Offspring Vascular Health
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it included both the first and second trimester, while ours used
hemoglobin concentrations before 18 weeks gestation. In our
analysis, using a bigger sample, stratification by intake of iron
supplements did not change the null result of the association with
BP (results available from authors on request).
Strengths & Limitations
Ours is a relatively large study and the first to examine the
association of maternal iron intake and maternal hemoglobin in
pregnancy with measures of offspring arterial stiffness, endothelial
function and adiposity, as well as with BP We have attempted to
assess mediation and effect modification based on existing
evidence to explain the mechanisms underlying any observed
associations. Maternal hemoglobin in early pregnancy was
objectively measured as part of routine antenatal care, and
extracted for cohort participants from medical records, making
bias due to selection and measurement unlikely. Although anemia
does not represent a specific or sensitive measure of body iron
stores, it is likely to reflect iron deficiency when it is pronounced,
particularly in the first trimester [41].
An important limitation of this study is that a biomarker of
maternal iron status during pregnancy, such as serum ferritin, or
transferrin receptor was not available in this study. Although there
are reservations about the use of serum ferritin as a sole measure of
iron status as it is an acute inflammatory marker [42], it remains a
better indicator compared to self-reported iron intake or
hemoglobin concentration [42]. Dietary iron was assessed by
self-report, using a food frequency questionnaire, which may
provide less accuracy than more detailed methods of dietary
assessment such as weighed food diaries. Furthermore, the long
term exposure of interest is cardiovascular events, which we are
unable to assess in this cohort due to their young age.
It is also known that heme iron is absorbed better than non-
heme iron. Although vegetarians often take iron supplements,
these may not be as effective as the heme iron that is missing from
their diets, and this may have a bearing on the interpretation of
our results. However, results based on hemoglobin concentrations
in the blood were broadly consistent with those based on dietary
intake, suggesting that the source of the iron was not relevant here.
Iron supplement intake was self-reported and the nature of the
questions used in this study mean that we do not know the amount
of supplementation or whether the iron supplementation was in
the form of iron only or as part of a multivitamin preparation.
Therefore the association we observed between maternal reported
iron supplementation and offspring systolic BP could be attribut-
able to other micronutrient supplements that the mother was
taking as well or our null associations may be masked since iron
taken as part of a multivitamin preparation may be less readily
absorbed compared to when taken on its own [43,44,45]. It is
difficult to conduct analyses in a British cohort study of iron-only
supplements as the exposure. Firstly because, in the UK, these are
not recommended routinely in pregnancy, therefore a small
proportion of pregnant women would be expected to use them.
Secondly, those who take iron-only supplements are likely to be
taking the prescribed high-dose as opposed to the low-dose
recommended routinely during pregnancy in other countries.
The study sample analysed to test mediation by cord ferritin was
considerably smaller. Therefore, when examining the association
between maternal iron supplement intake and offspring systolic
BP, lack of statistical power may explain the difference in the
results between the complete data and multiple imputation models
(tables 3 & 4).
In conclusion, this study suggests that maternal anemia during
early pregnancy is not an important determinant of future
offspring cardiovascular health, using childhood vascular and
adiposity indicators at 10 years. We also did not observe any
associations between maternal iron intake in pregnancy with
offspring’s vascular markers and adiposity except for a modest
inverse association between self-reported maternal iron supple-
ment intake during pregnancy and offspring BP.
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